Abstract
Migraine is a widespread disorder with a large impact on society. Patent foramen ovale (PFO) is a common occurrence, affecting about 25 % of the population. Observational studies report PFO to be more prevalent in patients with migraine with aura, and patients with migraine with aura have a higher incidence of PFO. The only population-based study does not support this link. It is possible that an association exists between large-sized PFO and migraine. This association may explain how migraine with aura can be triggered. Numerous studies have reported improved migraine with PFO closure, but the only prospective placebo-controlled trial aimed at closure of PFO in patients with migraine with aura did not support this. At this time, evidence does not support the routine detection and closure of PFO in patients with migraine.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States; Data from the American Migraine Study II. Headache. 2001;41:646–57.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders 3rd Edition (beta version). Cephalalgia. 2013;33:645–66.
Weber F, Goriup A. Prevalence of right to-left shunts in active fighter pilots. Aviat Space Environ Med. 2007;78:135–6.
• Sharma A, Gheewala N, Silver P. Role of patent foramen ovale in migraine etiology and treatment: a review. Echocardiography. 2011;28:913–7. Good review of data.
Schwedt TJ, Dodick DW. Patent foramen ovale and migraine-bringing closure to the subject. Headache. 2006;46:663–71.
Downson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397–404. J Interv Cardiol. 2003;16:39–42.
•• Schwerzmann M, Meirer B. Impact of percutaneous patent foramen ovale closure on migraine course. Interv Cardiol. 2013;5:177–87. Thorough review of data on PFO and migraine.
Di Tullio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24:1020–4.
Zito C, Dattillo G, Oreto G, et al. Patent foramen ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography. 2009;26:495–503.
Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systemic review. Cephalalgia. 2008;28:531–40.
Garg P, Servoss SJ, Wu JC, et al. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010;112:1406–12.
Davis D, Gregson J, Willeit P, et al. Patent foramen ovale, ischemic stroke and migraine: systemic review and stratified meta-analysis of association studies. Neuroepidemiology. 2012;40:56–67.
Rundek T, Elkin MS, Di Tullio MR, et al. Patent foramen ovale and migraine: a cross-sectional study from the northern manhattan study (NOMAS). Circulation. 2008;118:1419–24.
Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci. 2001;100:215–20.
Wilmshurst P, Pearson M, Nightingale S. Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci. 2005;108:365–7.
Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology. 2005;65:1415–8.
Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765–7.
Jesurum JT, Fuller CJ, Velez CA, et al. Migraineurs with patent foramen ovale have a larger right-to-left shunt on transcranial Doppler: a case control study. J Headache Pain. 2007;8:209–16.
• van Gent MWF, Mager JJ, Snijder RJ, et al. Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt. J Cardiol. 2011;107:1399–404. Interesting study of migraine and shunt size.
• Chambers J, Seed PT, Ridsdale L. Association of migraine aura with patent foramen ovale and atrial septal aneurysms. Int J Cardiol. 2013;168:3949–53. Sites incidence of PFO in patients with migraine.
• McCandless RT, Arrington CB, Nielsen DC, et al. Patent foramen ovale in children with migraine headaches. J Pediatr. 2011;159:243–7. Only article looking at PFO in children with migraine.
Zeller JA, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004;75:984–7.
Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J. 2006;151:922.e1–5.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173–5.
Kaaro J, Partonen, Naik P, et al. Is migraine a lateralization defect? Neuroreport. 2008;19:1351–3.
Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair. A case-control study. Stroke. 2006;37:430–4.
Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol. 2003;16:39–42.
Jesurum JT, Fuller CJ, Kim CJ, et al. Frequency of migraine headache relief following patent foramen ovale “closure” despite residual right-to-left shunt. Am J Cardiol. 2008;102:916–20.
Lutermans J, Post MC, Temmerman F, et al. Closure of patent foramen ovale is associated with a decrease in prevalence of migraine: a prospective observational study. Acta Cardiol. 2008;63:571–7.
Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62:1399–401.
Post MC, Thijs V, Herroelen L, et al. Closure of patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004;62:1439–40.
Reisman M, Chistofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45:493–5.
Slavin L, Tobis JM, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol. 2007;99:1316–20.
Dubiel M, Brush L, Schmehl I, et al. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol. 2008;21:32–7.
Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–51.
Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol. 2005;4:489–92.
•• Butera G, Biondi-Zoccai GG, Carminati M, et al. Systemic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovasc Interv. 2010;75:494–504. Only meta-analysis of PFO closure trials.
Rigatelli G, Dell’Avvocata F, Ronco F, et al. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv. 2010;3:282–7.
Rigatelli G, Dell’Avvocata F, Cardaioli P, et al. Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow up. Am J Cardiovasc Dis. 2012;2:89–95.
Trabattoni D, Fabbiocchi F, Montosrsi P, et al. Sustained long-term benefit of patent foramen ovale closure on migraine. Catheter Cardiovasc Interv. 2011;77:570–4. Accessed 24 Dec 2013.
Khessali H, Mojadidi MK, Gevorgyan R, et al. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache. JACC Cardiovasc Interv. 2012;5:682–7.
PREMIUM. http://clinicaltrials.gov/ct2/show/NCT00355056. Accessed 24 Dec 2013.
PRIMA. http://www.clinicaltrials.gov/ct2/show/NCT00505570. Accessed 24 Dec 2013.
MIST II. http://www.clinicaltrials.gov/ct2/show/NCT00283738. Accessed 24 Dec 2013.
ESCAPE. http://www.clinicaltrials.gov/ct2/show/NCT0267371. Accessed 24 Dec 2013.
Compliance with Ethics Guidelines
Conflict of Interest
Jessica Ailani declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Headache
Rights and permissions
About this article
Cite this article
Ailani, J. Migraine and Patent Foramen Ovale. Curr Neurol Neurosci Rep 14, 426 (2014). https://doi.org/10.1007/s11910-013-0426-4
Published:
DOI: https://doi.org/10.1007/s11910-013-0426-4